Goldman Sachs Group Inc Clear Point Neuro, Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 29,150 shares of CLPT stock, worth $453,282. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,150
Previous 126,584
76.97%
Holding current value
$453,282
Previous $682,000
52.2%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CLPT
# of Institutions
83Shares Held
6.81MCall Options Held
84.3KPut Options Held
56.7K-
Vanguard Group Inc Valley Forge, PA1.24MShares$19.3 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA464KShares$7.21 Million0.97% of portfolio
-
Taylor Frigon Capital Management LLC375KShares$5.83 Million2.12% of portfolio
-
Black Rock Inc. New York, NY366KShares$5.7 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$5.18 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $381M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...